A.R. CARD Onlus Foundation   Report issue

Foundation Phase 4
Founded: Florence Italy

Organization Overview

First Clinical Trial
2012
NCT01790854
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

prasugrel (effient) (2 trials)

ticagrelor (brilinta) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2